At Beijing GoBroad Boren Hospital, we’ve dedicated ourselves to advancing leukemia cures and treatments through cutting-edge technology, multidisciplinary collaboration, and compassionate care. As a leading institution in hematologic oncology, our mission is to provide personalized, holistic care for patients facing leukemia and other blood-related conditions. With state-of-the-art facilities, a globally recognized medical team, and innovative therapies, we stand at the forefront of leukemia treatment, offering hope to patients of all ages.

Advanced Infrastructure for Precision Care

Our hospital’s foundation lies in its world-class infrastructure, designed to support the complexities of leukemia cures and treatments. Spanning 14,000 square meters, our facility houses 19 level-100 laminar flow wards, specialized operating rooms, and emergency units equipped with Siemens 64-slice spiral CT and 3.0T MRI systems. These resources enable precise diagnostics and targeted therapies, critical for managing both childhood and adult leukemia. Our focus on cellular immunotherapy, particularly CAR-T therapy for refractory cases, has positioned us as a global hub for hematologic tumor treatment. By integrating advanced equipment with tailored treatment plans, we ensure every patient receives care that aligns with their unique needs.

A Global Network of Medical Experts

What truly sets GoBroad Boren Hospital apart is our team of internationally renowned specialists. Collaborating with experts from institutions like the Mayo Clinic and MD Anderson Cancer Center, our physicians bring over 30 years of experience in hematologic disease management. Our interdisciplinary teams—combining hematology with infection imaging, pulmonology, and more—work seamlessly to address complications and optimize outcomes. For instance, Dr. Chunrong Tong and Dr. Yonghong Zhang lead groundbreaking work in hematopoietic stem cell transplants, achieving success even in high-risk cases, such as patients aged 72 or infants as young as one month. This collective expertise ensures that leukemia cures and treatments here are guided by the latest research and hands-on innovation.

Pioneering Research and Personalized Therapies

Innovation drives our approach to leukemia cures and treatments. Beyond standard chemotherapy and radiation, we specialize in immunotherapy, targeted therapies, and demethylation techniques. Our achievements in CAR-T cell therapy for acute lymphoblastic leukemia and multiple myeloma have been showcased at international conferences, earning global acclaim. Additionally, our hematopoietic stem cell transplant program boasts a success rate matching international benchmarks, with unique strategies in haploidentical and salvage transplants. By bridging CAR-T therapy with transplants, we’ve opened new pathways for relapsed or resistant leukemia cases. Our labs further support this progress, offering genetic analysis, flow cytometry, and pharmacogenetic testing to refine treatment plans.

Conclusion

At GoBroad Boren Hospital, we believe in turning scientific breakthroughs into tangible solutions for leukemia cures and treatments. From advanced infrastructure to a globally connected medical team and pioneering research, every aspect of our care is designed to empower patients. Whether through CAR-T therapy, stem cell transplants, or personalized diagnostics, we remain committed to redefining what’s possible in leukemia treatment.